Portal de investigación
Efficacy and safety evaluation of Fanhdi ® , a plasma-derived factor VIII/ von Willebrand factor concentrate, in Von Willebrand's disease patients undergoing surgery or invasive procedures: A prospective clinical study.
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Jimenez-Yuste, Victor
- Núñez L
- Alvarez-Roman, Maria Teresa
- Martin-Salces, Monica
- Federici, Augusto B.
- Grifols, Carlota
- Mairal, Esther
- Torres, Mireia
- Paez, Antonio
Grupos
Abstract
[No abstract available]
Datos de la publicación
- ISSN/ISSNe:
- 1351-8216, 1365-2516
- Tipo:
- Letter
- Páginas:
- 23-27
- DOI:
- 10.1111/hae.14453
- PubMed:
- 34735040
- Enlace a otro recurso:
- www.scopus.com
- Factor de Impacto:
- 1,449 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
HAEMOPHILIA WILEY
Citas Recibidas en Web of Science: 2
Documentos
- No hay documentos
Filiaciones
Keywords
- Factor VIII; Hemophilia A; Humans; Prospective Studies; von Willebrand Diseases; von Willebrand Factor; blood clotting factor 8; von Willebrand factor; hemophilia A; human; prospective study; von Willebrand disease
Campos de Estudio
Cita
Jimenez V,Núñez L,Alvarez MT,Martin M,Haya S,Federici AB,Grifols C,Mairal E,Torres M,Paez A. Efficacy and safety evaluation of Fanhdi ® , a plasma-derived factor VIII/ von Willebrand factor concentrate, in Von Willebrand's disease patients undergoing surgery or invasive procedures: A prospective clinical study. Haemophilia. 2022. 28(1):p. 23-27. IF:3,900. (2).